


Day By Day Home Care Maintenance Hair Treatment Kit 2x 300 - Rovely
Marsoni
M251S
Get it in 3 business days with 1 day shipping.
Friday, May 29
Day By Day Home Care Maintenance Hair Treatment Kit 2x 300 - RovelyDeveloped for care at home, it is essential for all women who undergo chemical treatments, dyes, discolorations, or who suffer from daily aggressions. HYDROLYZED KERATIN It acts in the reconstruction of the hair fiber, providing resistance to the breakdown of chemically damaged hair, leaving it soft and shiny all day. GRAPE SEED OIL Provides emolliency, nutrition, shine with antioxidant action for fiber. PANTHENOL (VITAMIN B5) Ensures moisturizing
Quick Dispatch:
Your Day By Day Home Care Maintenance Hair Treatment Kit 2x 300 - Rovely orders ship within 1-2 business days.
Delivery Options:
- Standard: 3-7 business days
- Fast: 2-3 business days
- Express: 1-2 business days
Order Tracking:
You'll receive a tracking link by email once your Day By Day Home Care Maintenance Hair Treatment Kit 2x 300 - Rovely ships.
Need Help?
Questions about Day By Day Home Care Maintenance Hair Treatment Kit 2x 300 - Rovely, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Day By Day Home Care Maintenance Hair Treatment Kit 2x 300 - Rovely in your area.
Get Shipping Estimates
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
4.6 ★★★★★
Based on 1289 reviews
Sort
Product Reviews
★★★★★ 1
This book will crush infertile couples
Format: Paperback
I don't know how this book has a 5-star review rating. It's poorly researched and lacks any depth on the very subject it's supposed to be dealing with. The first section on Birth-Control just goes on and on about how Children are a Blessing and a Reward from God. And it says in one of the footnotes that the only reason couples shouldn't have kids is if the wife has a medical condition that would make pregnancy life-threatening or they are too old when they got married. Infertility isn't even mentioned. In the section on Infertility, there is NO research on how common it is, what causes it, etc. It's just Infertility is hard on women, and men will never quite understand why. And then on ARTs, they are treated as a guarantee that a couple will have kids if they do the treatment. The one and only stat he cites in this section is on IVF and he clearly read the information wrong. He didn't look to see what the difference is between cycles and transfers and said that IVF has over a 50% success rate in women under 34. That number is way too high and will only cause false hope, and misunderstandings about childless couples. And some of his research was from 2007, making it out of date in this cutting-edge technology.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 12, 2022
★★★★★ 5
Great reference
Format: Paperback
This book is well organized and easy to follow. As a nurse educator, this will be a great supplement to my toolbox.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 21, 2023
★★★★★ 1
Poor spelling and grammar
Format: Paperback
Numerous spelling and grammar mistakes. Gives some wrong information (remeron and ramelteon are NOT the same med).
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 18, 2023
★★★★★ 5
Easy to follow with helpful info
Format: Kindle
Book is well-written and easy to follow. The Interprofessional box at the end of each chapter provides helpful nuggets of information related to treatment options, client education, and resources.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 12, 2023
★★★★★ 5
Great information
Format: Paperback
Great information for the elderly! Easy to follow and understand.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 24, 2023